REDWOOD CITY, Calif. and NEW YORK, Sept. 27, 2016 -- BlueTalon, the leader in Data-Centric Security, announced today the availability of BlueTalon Test Drive, making it easy for organizations to trial its award-winning data-aware security. In celebration of this milestone and for a limited time, BlueTalon is making BlueTalon Test Drive available at no charge to attendees of Strata+Hadoop World.
Data security is one of the remaining challenges preventing organizations from maximizing the power of new big data technology. The proliferation of data storage and processing tools in support of big data initiatives is leaving businesses exposed to new vulnerabilities including the inability to monitor and track who is accessing what data. By applying data access controls at the data layer, BlueTalon eliminates security blind spots where it matters the most: at the data layer.
The BlueTalon Test Drive provides an opportunity to easily trial BlueTalon security for one month and evaluate how data-aware access controls can simplify security and compliance on big data technology such as Hadoop. Organizations who sign-up for the test drive will receive at no charge:
- A 30-day license to the software, including a self-contained and pre-configured environment to experience BlueTalon on a Hadoop cluster;
- Two hours of consulting support from a BlueTalon expert;
- The ability to build visibility reports relevant to their use of big data platforms.
"Data-driven businesses are now using Hadoop, Spark, or NoSQL to power new data initiatives. Unfortunately, traditional security is no longer sufficient to satisfy users’ increasing demand for access to more data while security and compliance requirements get tighter," said Eric Tilenius, chief executive officer, BlueTalon. "BlueTalon is propelling data security into a new era. With visibility and control directly applied to data, businesses can address both data security and compliance with less effort."
Qualified organizations can sign-up for BlueTalon Test Drive at booth #355 during Strata+Hadoop World New York held at the Javits Convention Center, Sept. 26 – 29, 2016.
About BlueTalon, Inc.
BlueTalon is a leading provider of data-centric security for big data and new data initiatives. The BlueTalon Policy Engine delivers precise, consistent, and dynamic user access controls to data across Hadoop, Spark, Cassandra, and SQL-based data platforms. The BlueTalon Audit Engine provides a full audit trail at the level of detail required for regulatory compliance and data security.
Leading Fortune 100 companies rely on BlueTalon to eliminate security blind spots and gain visibility and control at the data layer across cloud-based and on-premises environments. BlueTalon was named a 2016 Gartner “cool vendor” and has won numerous security and big data awards.
Learn more about BlueTalon at http://www.bluetalon.com
Contact: Isabelle Dumont Email: [email protected] Phone: 650-799-7542


Apple Turns 50: From Garage Startup to AI Crossroads
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Britain Courts Anthropic Amid US Defense Department Dispute
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 



